These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1465998)

  • 21. Beneficial effect of syngeneic pancreatic islet transplantation on liver atrophy and hepatocellular function after portacaval shunt.
    Nakafusa Y; Goss JA; Roland CR; Lacy PE; Flye MW
    Surgery; 1992 Aug; 112(2):309-17; discussion 317-8. PubMed ID: 1641769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the numbers of islets on the models of rat syngeneic-islet and allogeneic-islet transplantations.
    Hara Y; Fujino M; Nakada K; Kimura K; Adachi K; Li XK
    Transplant Proc; 2006 Oct; 38(8):2726-8. PubMed ID: 17098051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of transplant site on islet allograft survival in BB rats.
    Woehrle MF; Markmann JF; Armstrong J; Naji A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):925-7. PubMed ID: 3152638
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 26. Intrathymic islet allografts prevent hyperglycemia and autoimmune beta-cell destruction in BB rats following transplantation in the prediabetic period.
    Brayman KL; Nakai I; Field J; Lloveras JJ; Farney A; Najarian JS; Sutherland DE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):284-5. PubMed ID: 8438301
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatic insufficiency after portacaval shunting is prevented by prior intraportal pancreatic islet autotransplantation.
    Callery MP; Ricordi C; Scharp DW; Kamei T; Swanson CJ; Lacy PE; Flye MW
    Surgery; 1989 Aug; 106(2):257-65; discussion 265-6. PubMed ID: 2503900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged survival of intraportal versus subrenal capsular transplanted islet allografts.
    Gores PF; Rabe F; Sutherland DE
    Transplantation; 1987 May; 43(5):747-9. PubMed ID: 3107179
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolerance of islet allografts induced by orthotopic liver transplantation.
    Sawada T; Asanuma Y; Furuya T; Saito K; Koyama K
    J Surg Res; 1999 Aug; 85(2):209-16. PubMed ID: 10423321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic islets enhance hepatocellular survival in combined hepatocyte-islet-cell transplantation.
    Ricordi C; Callery MP; Lacy PE; Flye MW
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2689-90. PubMed ID: 2495668
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK 506.
    Tze WJ; Tai J; Cheung SS; Bissada N; Starzl TE
    Transplant Proc; 1994 Apr; 26(2):777-8. PubMed ID: 7513471
    [No Abstract]   [Full Text] [Related]  

  • 32. Surviving native beta-cells determine outcome of syngeneic intraportal islet transplantation.
    Hughes SJ; Powis SH; Press M
    Cell Transplant; 2001; 10(2):145-51. PubMed ID: 11332628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of MHC-incompatible intraportal islet and vascularized whole-pancreas transplantation in the prehyperglycemic phase of autoimmune diabetes.
    Nakai I; Oda T; Mitsuo M; Shimizu Y; Arakawa K; Oka T; Sutherland DE; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):738. PubMed ID: 8171634
    [No Abstract]   [Full Text] [Related]  

  • 34. Time course of islet loss after intraportal transplantation.
    Pawelec K; Juszczak MT; Kumar A; Powis SH; Press M
    Ann N Y Acad Sci; 2008 Dec; 1150():230-3. PubMed ID: 19120301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic nitric oxide generation as a putative mechanism for failure of intrahepatic islet cell grafts.
    Nussler AK; Carroll PB; Di Silvio M; Rilo HL; Simmons RL; Starzl TE; Ricordi C
    Transplant Proc; 1992 Dec; 24(6):2997. PubMed ID: 1466032
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful experimental heart transplantation without immunosuppressive drugs.
    Kline GM; Shen Z; Mohiuddin M; Ruggiero V; Rostami S; DiSesa VJ
    J Heart Lung Transplant; 1993; 12(3):388-93. PubMed ID: 8329408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of mycophenolate mofetil on islet allografting to chemically induced or spontaneously diabetic animals.
    Hao L; Wang Y; Chan SM; Lafferty KJ
    Transplant Proc; 1992 Dec; 24(6):2843-4. PubMed ID: 1465967
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of hepatocyte-rich liver cell mixture and liver fibroblasts on prolonging graft islet survival in rats without immunosuppressive drugs.
    Soto-Montenegro L; Zugasti-Murillo A; Rollán E; Alvarez Y; Alvarez G; Jara-Albarrán A
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):580-6. PubMed ID: 15578333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of intrathymic induction of tolerance in outbred rat strains.
    Weide LG
    Transplant Proc; 1994 Dec; 26(6):3327-8. PubMed ID: 7998157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.